Cite

HARVARD Citation

    Wu, C. et al. (2021). Association between proton pump inhibitor use and mortality in patients with hepatocellular carcinoma receiving tyrosine kinase inhibitor. Gut. 70 (8), pp. 1598-1599. [Online]. 
  
Back to record